Giulia Mammone

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 77 citations · Full text

Medicine, Immunology, Oncology +14

The role of opioids in cancer response to immunotherapy

Andrea Botticelli, Alessio Cirillo, Giulia Pomati et al. · Journal of Translational Medicine · 2021 · 41 citations · Full text

Medicine, Oncology, Pharmacology +15

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 41 citations · Full text

Medicine, Immunology, Oncology +12

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Matteo Santoni, Francesco Massari, Zin Myint et al. · Clinical Genitourinary Cancer · 2023 · 31 citations · Full text

Medicine, Oncology, Pathology +15

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

Ondřej Fiala, Sebastiano Buti, Hideki Takeshita et al. · Cancer Immunology Immunotherapy · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +12